Literature DB >> 24568834

Relevance of guideline-based ICD indications to clinical practice.

Nora Al-Jefairi1, Haran Burri2.   

Abstract

The implantable cardioverter-defibrillator (ICD) has established itself as life-saving therapy in patients at risk for sudden cardiac death. Remarkable technological advances have made ICDs easier and safer to implant, with improved therapeutic and diagnostic functions and reduced morbidity. Guidelines on ICD indications have been proposed by American and European scientific societies since a number of years, based upon trials and expert opinion. In the context of variable economic and political constraints, it is questionable whether these guidelines may be applied to all settings. This review discusses the guideline-based indications, critically examines their applicability to clinical practice, and discusses alternatives to ICD therapy.
Copyright © 2013 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Implantable cardioverter defibrillator; Indications; Sudden death

Mesh:

Year:  2013        PMID: 24568834      PMCID: PMC4237301          DOI: 10.1016/j.ihj.2013.11.006

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  33 in total

Review 1.  Implantable cardioverter defibrillator therapy: the sickest patients benefit the most.

Authors:  A J Moss
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

2.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

3.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

Authors:  S J Connolly; A P Hallstrom; R Cappato; E B Schron; K H Kuck; D P Zipes; H L Greene; S Boczor; M Domanski; D Follmann; M Gent; R S Roberts
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

6.  Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).

Authors:  Dietmar Bänsch; Matthias Antz; Sigrid Boczor; Marius Volkmer; Jürgen Tebbenjohanns; Karlheinz Seidl; Michael Block; Frank Gietzen; Jürgen Berger; Karl Heinz Kuck
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

7.  Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.

Authors:  Jürg Schläpfer; Fabrice Rapp; Lukas Kappenberger; Martin Fromer
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

8.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

9.  Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.

Authors:  Takekuni Hayashi; Seiji Fukamizu; Rintaro Hojo; Kota Komiyama; Yasuhiro Tanabe; Tamotsu Tejima; Kyoko Soejima; Mitsuhiro Nishizaki; Masayasu Hiraoka; Junya Ako; Shin-Ichi Momomura; Harumizu Sakurada
Journal:  Europace       Date:  2013-04-19       Impact factor: 5.214

10.  Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.

Authors:  S Adam Strickberger; John D Hummel; Thomas G Bartlett; Howard I Frumin; Claudio D Schuger; Scott L Beau; Cynthia Bitar; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  1 in total

1.  First appropriate implantable defibrillator shocks in patients with Chagasic heart disease

Authors:  Luis G García-Chamorro; Ezequiel J Zaidel; Lara Gheco; Matías A Oliva; Alejandro de-la-Vega; Agustín Orosco; Juan Armentano; Álvaro Sosa-Liprandi
Journal:  Arch Cardiol Mex       Date:  2022-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.